MEDITE Cancer Diagnostics Inc – Strategy, SWOT and Corporate Finance Report

MEDITE Cancer Diagnostics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, and cytology screening systems. The company’s products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. MEDITE is headquartered in Orlando, Florida, the US.

Scope

Detailed information on MEDITE Cancer Diagnostics Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting MEDITE Cancer Diagnostics Inc in the form of a SWOT analysis

An in-depth view of the business model of MEDITE Cancer Diagnostics Inc including a breakdown and examination of key business segments

News about MEDITE Cancer Diagnostics Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of MEDITE Cancer Diagnostics Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess MEDITE Cancer Diagnostics Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on MEDITE Cancer Diagnostics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Cytyc Surgical Products

Dako A/S

Leica Biosystems Nussloch Gmbh

Sakura Finetek USA, Inc.

Thermo Fisher Scientific Inc

TriPath Imaging Inc

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

MEDITE Cancer Diagnostics Inc - Key Facts 5

MEDITE Cancer Diagnostics Inc - Key Employees 6

MEDITE Cancer Diagnostics Inc - Key Employee Biographies 7

MEDITE Cancer Diagnostics Inc - Major Products and Services 8

MEDITE Cancer Diagnostics Inc - History 9

MEDITE Cancer Diagnostics Inc - Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2 Company Analysis 12

Company Overview 12

MEDITE Cancer Diagnostics Inc - Business Description 13

MEDITE Cancer Diagnostics Inc - SWOT Analysis 14

SWOT Analysis - Overview 14

MEDITE Cancer Diagnostics Inc - Strengths 14

MEDITE Cancer Diagnostics Inc - Weaknesses 15

MEDITE Cancer Diagnostics Inc - Opportunities 16

MEDITE Cancer Diagnostics Inc - Threats 17

MEDITE Cancer Diagnostics Inc - Key Competitors 18

Section 3 Company Financial Ratios 19

Financial Ratios - Capital Market Ratios 19

Financial Ratios - Annual Ratios 20

Performance Chart 23

Financial Performance 23

Financial Ratios - Interim Ratios 24

Financial Ratios - Ratio Charts 25

Section 4 Company’s Lifesciences Financial Deals and Alliances 26

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 27

MEDITE Cancer Diagnostics Inc, Recent Deals Summary 28

Section 5 Company’s Recent Developments 29

Nov 15, 2017: MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director 29

Nov 08, 2017: MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer 30

Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results 31

Jul 27, 2017: MEDITE Cancer Diagnostics to Launch SureCyte C1 Stain Globally at the 29th European Congress of Pathology 33

May 10, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 34

Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 35

Apr 27, 2017: MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer 36

Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors 37

Section 6 Appendix 38

Methodology 38

Ratio Definitions 38

About GlobalData 42

Contact Us 42

Disclaimer 42

List of Tables

List of Tables

MEDITE Cancer Diagnostics Inc, Key Facts 5

MEDITE Cancer Diagnostics Inc, Key Employees 6

MEDITE Cancer Diagnostics Inc, Key Employee Biographies 7

MEDITE Cancer Diagnostics Inc, Major Products and Services 8

MEDITE Cancer Diagnostics Inc, History 9

MEDITE Cancer Diagnostics Inc, Subsidiaries 11

MEDITE Cancer Diagnostics Inc, Key Competitors 18

MEDITE Cancer Diagnostics Inc, Ratios based on current share price 19

MEDITE Cancer Diagnostics Inc, Annual Ratios 20

MEDITE Cancer Diagnostics Inc, Annual Ratios (Cont…1) 21

MEDITE Cancer Diagnostics Inc, Annual Ratios (Cont…2) 22

MEDITE Cancer Diagnostics Inc, Interim Ratios 24

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 27

MEDITE Cancer Diagnostics Inc, Recent Deals Summary 28

Currency Codes 38

Capital Market Ratios 38

Equity Ratios 39

Profitability Ratios 39

Cost Ratios 40

Liquidity Ratios 40

Leverage Ratios 41

Efficiency Ratios 41

List of Figures

List of Figures

MEDITE Cancer Diagnostics Inc, Performance Chart (2013 – 2017) 23

MEDITE Cancer Diagnostics Inc, Ratio Charts 25

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26

MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 27

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports